628 related articles for article (PubMed ID: 26382580)
1. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
[TBL] [Abstract][Full Text] [Related]
2. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Rizzardini G; Eskesen D; Calder PC; Capetti A; Jespersen L; Clerici M
Br J Nutr; 2012 Mar; 107(6):876-84. PubMed ID: 21899798
[TBL] [Abstract][Full Text] [Related]
4. Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over study.
Childs CE; Röytiö H; Alhoniemi E; Fekete AA; Forssten SD; Hudjec N; Lim YN; Steger CJ; Yaqoob P; Tuohy KM; Rastall RA; Ouwehand AC; Gibson GR
Br J Nutr; 2014 Jun; 111(11):1945-56. PubMed ID: 24661576
[TBL] [Abstract][Full Text] [Related]
5. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
6. Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis.
Wildt S; Munck LK; Vinter-Jensen L; Hanse BF; Nordgaard-Lassen I; Christensen S; Avnstroem S; Rasmussen SN; Rumessen JJ
Inflamm Bowel Dis; 2006 May; 12(5):395-401. PubMed ID: 16670529
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB-12
Nocerino R; De Filippis F; Cecere G; Marino A; Micillo M; Di Scala C; de Caro C; Calignano A; Bruno C; Paparo L; Iannicelli AM; Cosenza L; Maddalena Y; Della Gatta G; Coppola S; Carucci L; Ercolini D; Berni Canani R
Aliment Pharmacol Ther; 2020 Jan; 51(1):110-120. PubMed ID: 31797399
[TBL] [Abstract][Full Text] [Related]
8. Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and Bloating.
Ringel-Kulka T; McRorie J; Ringel Y
Am J Gastroenterol; 2017 Jan; 112(1):145-151. PubMed ID: 27845337
[TBL] [Abstract][Full Text] [Related]
9. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.
Merenstein DJ; Tan TP; Molokin A; Smith KH; Roberts RF; Shara NM; Mete M; Sanders ME; Solano-Aguilar G
Gut Microbes; 2015; 6(1):66-77. PubMed ID: 25569274
[TBL] [Abstract][Full Text] [Related]
10. Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals.
West NP; Horn PL; Pyne DB; Gebski VJ; Lahtinen SJ; Fricker PA; Cripps AW
Clin Nutr; 2014 Aug; 33(4):581-7. PubMed ID: 24268677
[TBL] [Abstract][Full Text] [Related]
11. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
12. Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study.
Guyonnet D; Schlumberger A; Mhamdi L; Jakob S; Chassany O
Br J Nutr; 2009 Dec; 102(11):1654-62. PubMed ID: 19622191
[TBL] [Abstract][Full Text] [Related]
13. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
[TBL] [Abstract][Full Text] [Related]
14. Heat-inactivated Bifidobacterium bifidum MIMBb75 (SYN-HI-001) in the treatment of irritable bowel syndrome: a multicentre, randomised, double-blind, placebo-controlled clinical trial.
Andresen V; Gschossmann J; Layer P
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):658-666. PubMed ID: 32277872
[TBL] [Abstract][Full Text] [Related]
15. Effects of 28-day Bifidobacterium animalis subsp. lactis HN019 supplementation on colonic transit time and gastrointestinal symptoms in adults with functional constipation: A double-blind, randomized, placebo-controlled, and dose-ranging trial.
Ibarra A; Latreille-Barbier M; Donazzolo Y; Pelletier X; Ouwehand AC
Gut Microbes; 2018; 9(3):236-251. PubMed ID: 29227175
[TBL] [Abstract][Full Text] [Related]
16.
Martoni CJ; Srivastava S; Leyer GJ
Nutrients; 2020 Jan; 12(2):. PubMed ID: 32019158
[TBL] [Abstract][Full Text] [Related]
17. Effect of combined bifidobacteria supplementation and resistance training on cognitive function, body composition and bowel habits of healthy elderly subjects.
Inoue T; Kobayashi Y; Mori N; Sakagawa M; Xiao JZ; Moritani T; Sakane N; Nagai N
Benef Microbes; 2018 Dec; 9(6):843-853. PubMed ID: 30198326
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
20. Effect of multispecies probiotics on irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Yoon JS; Sohn W; Lee OY; Lee SP; Lee KN; Jun DW; Lee HL; Yoon BC; Choi HS; Chung WS; Seo JG
J Gastroenterol Hepatol; 2014 Jan; 29(1):52-9. PubMed ID: 23829297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]